Visceral Fat & Insulin Resistance Panel
Evaluate metabolic health and insulin sensitivity with the Visceral Fat and Insulin Resistance Panel. This panel includes glucose, insulin, lipid, inflammation, and liver markers to provide insight into visceral fat related metabolic function, energy regulation, and cardiometabolic risk factors.
- $561.33
- $129
- Save: 77.02%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Insulin (fasting)
Insulin
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
LDL/HDL Ratio
Non HDL Cholesterol
Triglycerides
The Visceral Fat & Insulin Resistance Panel panel contains 6 tests with 32 biomarkers .
A Comprehensive Evaluation of Metabolic Function and Insulin Sensitivity
The Visceral Fat and Insulin Resistance Panel is a comprehensive blood test designed to evaluate key biomarkers associated with metabolic health, insulin sensitivity, and the physiological effects of visceral fat. Visceral fat is metabolically active and closely linked to changes in glucose regulation, lipid metabolism, inflammation, and liver function. This panel combines foundational metabolic tests with additional markers that provide deeper insight into insulin dynamics and systemic inflammation.
By including the Comprehensive Metabolic Panel, Lipid Panel, and Hemoglobin A1c alongside fasting insulin, high sensitivity C reactive protein, and gamma glutamyl transferase, this panel offers a multidimensional view of metabolic processes. Rather than focusing on a single pathway, it evaluates how glucose metabolism, lipid balance, liver activity, and inflammatory signaling interact. This integrated approach helps provide a clearer understanding of metabolic efficiency and regulatory function.
Fasting insulin adds an important layer by reflecting how the body is responding to glucose at the hormonal level, while Hemoglobin A1c provides a longer term view of blood sugar regulation. High sensitivity C reactive protein offers insight into low grade systemic inflammation, and gamma glutamyl transferase provides additional context for liver function and oxidative stress. Together, these markers help create a more complete picture of metabolic health.
The panel is designed to support both baseline assessment and ongoing monitoring. It is particularly useful for identifying patterns associated with insulin resistance and visceral fat related metabolic changes, offering structured and clinically relevant insight into overall metabolic function.
When and Why Someone Would Order This Panel
Situations That May Prompt Evaluation of Insulin Resistance and Visceral Fat
The Visceral Fat and Insulin Resistance Panel may be considered when there is a need to better understand how the body is regulating glucose, processing lipids, and responding to metabolic stress. Visceral fat is associated with changes in insulin signaling, inflammation, and liver function, making these areas important to evaluate together when exploring metabolic health.
This panel may be ordered in situations where there are concerns related to energy balance, weight distribution, or changes in metabolic performance. Individuals who notice increased abdominal fat accumulation may seek a more detailed assessment of how their metabolism is functioning, even though fat distribution itself is not directly measured through blood tests. The biomarkers included in this panel help provide insight into the metabolic processes often associated with visceral fat.
It may also be useful for evaluating long term glucose regulation and insulin response. Hemoglobin A1c reflects average blood glucose over several months, while fasting insulin provides additional context about how the body is managing glucose at the hormonal level. Together, these markers can help identify patterns that may not be apparent from glucose measurements alone.
Healthcare providers may consider this panel when assessing risk factors related to cardiometabolic health. Lipid levels, inflammatory markers, and liver enzymes are commonly evaluated when exploring patterns associated with metabolic syndrome, insulin resistance, or cardiovascular risk. High sensitivity C reactive protein can provide insight into low grade inflammation, while gamma glutamyl transferase may reflect liver related metabolic stress.
This panel may also be used for ongoing monitoring in individuals making lifestyle adjustments such as changes in diet, physical activity, or weight management strategies. By tracking these markers over time, it is possible to observe how metabolic pathways respond and adapt, supporting a more informed and personalized approach to health monitoring.
What Does the Panel Measure
Core Biomarker Categories and Their Roles
Glucose Regulation and Insulin Dynamics
Hemoglobin A1c measures the percentage of hemoglobin with glucose attached, reflecting average blood sugar levels over approximately two to three months. Fasting insulin evaluates how the pancreas is responding to glucose and provides insight into insulin sensitivity. When interpreted together, these markers help assess how effectively the body is regulating blood sugar and utilizing insulin.
Lipid Metabolism
The Lipid Panel measures total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, and triglycerides. These markers are essential for understanding how fats are transported and processed in the body. Lipid patterns are closely associated with metabolic health and may provide insight into cardiovascular risk and energy storage dynamics.
Comprehensive Metabolic Panel
The Comprehensive Metabolic Panel includes markers that evaluate glucose, kidney function, liver enzymes, electrolyte balance, and protein levels. Liver enzymes such as alanine aminotransferase and aspartate aminotransferase provide information about liver activity, while kidney markers and electrolytes reflect fluid balance and metabolic stability. These markers help provide a broad overview of organ function in relation to metabolism.
Inflammation Marker
High sensitivity C reactive protein is a marker of low grade systemic inflammation. It is often used to assess inflammatory activity that may not produce obvious symptoms but can be associated with metabolic changes and cardiovascular risk. Evaluating hs CRP alongside metabolic markers provides additional context for understanding overall physiological stress.
Liver Function and Oxidative Stress
Gamma glutamyl transferase is an enzyme associated with liver function and oxidative stress. It can provide insight into how the liver is responding to metabolic demands and may be useful when evaluating patterns related to fat metabolism and liver activity.
By combining these categories, the panel offers a comprehensive view of metabolic pathways that are closely linked to visceral fat and insulin resistance.
How Patients and Healthcare Providers Use the Results
Interpreting Metabolic and Hormonal Patterns
Results from the Visceral Fat and Insulin Resistance Panel are typically interpreted by examining relationships between glucose, insulin, lipid levels, inflammation, and liver function markers. Rather than relying on a single value, healthcare providers assess patterns across these systems to understand how the body is managing energy balance and metabolic regulation.
For example, Hemoglobin A1c and fasting insulin may be evaluated together to assess how effectively glucose is being controlled and how much insulin is required to maintain that control. Lipid markers provide additional insight into fat metabolism, while hs CRP may reflect underlying inflammatory processes that can influence metabolic health. Gamma glutamyl transferase and other liver markers help provide context for how the liver is processing nutrients and responding to metabolic stress.
Supporting Monitoring and Follow Up
This panel can be used to monitor changes over time, particularly in response to lifestyle modifications such as dietary changes, increased physical activity, or weight management efforts. Tracking trends in insulin, glucose, and lipid markers can help determine whether metabolic pathways are improving or require further attention. Repeated testing allows for a more dynamic understanding of metabolic health rather than relying on a single snapshot.
Clinical Context and Broader Health Insights
The results may contribute to the evaluation of conditions such as insulin resistance, metabolic syndrome, dyslipidemia, and metabolic associated liver changes. Inflammatory markers may provide additional context for cardiovascular risk, while liver enzymes can help identify patterns associated with metabolic stress on the liver. These insights can support further evaluation and guide clinical decision making.
It is important that results are interpreted within the context of overall health, lifestyle factors, and clinical history. This panel provides a comprehensive dataset that can help guide next steps, whether that involves additional testing, monitoring, or broader evaluation of metabolic health.
A Comprehensive Perspective on Metabolic Health and Insulin Sensitivity
The Visceral Fat and Insulin Resistance Panel offers a structured and comprehensive approach to evaluating key aspects of metabolic health. By combining foundational metabolic markers with insulin, inflammation, and liver specific biomarkers, it provides a multidimensional view of how the body regulates energy, processes nutrients, and responds to metabolic stress.
Visceral fat is closely linked to metabolic activity, and its effects are reflected in changes across multiple biological systems. This panel captures those changes by evaluating glucose regulation, lipid metabolism, inflammatory signaling, and liver function. The inclusion of fasting insulin adds an important dimension, allowing for a more complete understanding of insulin sensitivity and hormonal regulation.
Designed for both baseline assessment and ongoing monitoring, the panel supports a deeper understanding of metabolic patterns over time. It provides clinically relevant information that can help identify trends, support further evaluation, and contribute to a more informed approach to health monitoring.
By emphasizing clarity, completeness, and integration across systems, the Visceral Fat and Insulin Resistance Panel reinforces the value of a comprehensive approach to metabolic health. It serves as a reliable tool for exploring how metabolic processes function together and supports a more personalized understanding of insulin sensitivity and overall metabolic balance.